Washington/London: U.S. top epidemic expert Dr Anthony Pouch said on Thursday that Britain was not as rigorous as U.S. health authorities in the process of approving the COVID-19 vaccine
The UK on Wednesday became the first country in the world to approve a Pfizer/Bioentech vaccine against coronavirus. He told Fox News that “the UK wasn’t so cautious.” “If you go fast and do it superficially, people won’t want to be vaccinated.”
“We scrutinize the data very carefully to ensure to the American public that this vaccine is a safe and effective vaccine,” he said. “We have the gold standard of regulatory approach with the US Food and Drug Administration (FDA),” said 79-year-old expert. The UK didn’t do that very carefully and it was a few days ahead.”
Pfizer/BioNTech is the fastest vaccine on the way from concept to reality, it usually only takes 10 months to follow the same stages of development over 10 years. The UK advocated the approval process and said the jab was safe and effective.
Dr. June Raine, head of the UK’s pharmaceutical regulatory authority, said on Wednesday that “the corners weren’t cut off” in investigating the jab. The Pharmaceuticals and Medical Products Regulatory Authority (MHRA) has reviewed preliminary data for vaccine trials dating back to June.
Regulators said, “Unless the expected safety, quality and efficacy criteria are met, the vaccine supply will not be approved in the UK.”
On Thursday, British vice chairman Jonathan Van Tam told the BBC that he was “very confident” about MHRA. Dr. Fauci’s remarks brought the United States close to a total of 14 million COVID-19 infections, killing 273,590 people. The United States, the worst-hit from the pandemic, has yet to approve the coronavirus vaccine.
The chief physician said he believed the U.S. would get vaccine approval soon and supported the U.S. FDA and its review process. The FDA plans to discuss the approval of a UK-approved vaccine created through a partnership between Pfizer and BioNTech during a December 10 meeting.
They will meet again on December 17th to discuss Moderna’s request for a second vaccine. Dr. Fauci has led the U.S. National Institute of Allergy and Infectious Diseases (NIH) for over 30 years and has become one of the most prominent members of the Trump Administration’s White House Coronavirus Task Force.